ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1736	National Cancer Institute	Html	en	Surgery to Reduce the Risk of Breast Cancer	A fact sheet that describes mastectomy and salpingo-oophorectomy, two surgeries that may be used to reduce breast cancer risk in women at very high risk, and nonsurgical options.	Surgical Adjuvant Breast 0.509427 breast cancer talk 0.520216 primary breast cancer 0.51166 breast reconstruction surgery 0.528802 radiation-associated breast cancer 0.517996 breast health specialist 0.49326 Breast cancer phenotype 0.510792 Breast Cancer Research 0.511066 early-stage breast cancer 0.509281 breast screening 0.478516 cancer risk reduction 0.514817 bilateral risk-reducing mastectomy 0.474208 bilateral breast cancer 0.543505 ovarian cancer 0.506899 frequent breast cancer 0.518031 clinical breast examinations 0.496735 normal breast functions 0.496662 high risk 0.488512 invasive breast cancer 0.560151 Clinical Oncology 0.486116 primary breast cancers 0.493314 BRCA2 mutation carriers 0.492894 contralateral breast cancer 0.595168 women 0.553369	early breast cancer 0.515841 J. Prophylactic mastectomy 0.474619 appropriate cancer prevention 0.465287 prophylactic bilateral mastectomy 0.491713 breast cancer susceptibility 0.516869 breast cancer surgery 0.554904 prophylactic surgery 0.485463 breast cancers 0.51424 greatest breast cancer 0.535025 breast tissue 0.513481 Cancer Risk Assessment 0.465659 ovarian cancer risk 0.465289 breast surgeons 0.489292 postmenopausal women 0.468075 breast cancer risk 0.685989 breast cancer 0.963464 bilateral prophylactic mastectomy 0.680206 Breast Cancer Trialists 0.509574 prophylactic mastectomy 0.701891 Bilateral prophylactic salpingo-oophorectomy 0.47763 contralateral prophylactic mastectomy 0.553604 strong family history 0.509663 breast cancer-associated mutations 0.511851 et al 0.584443	CLICK HERE
1774	National Cancer Institute	Html	es	Fatiga (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca de la fatiga, una afección caracterizada por extremo cansancio e incapacidad para funcionar por la falta de energía, que a menudo se observa como una complicación del cáncer y su tratamiento.	adjuvant chemotherapy 0.23884 Cancer patients as 0.267855 cáncer respalda 0.229838 Breitbart W 0.226519 frase cansancio 0.380985 cancer-related fatigue 0.694477 FossÃ¥ SD 0.231004 critical appraisal 0.229895 Nail LM 0.242438 tripart assessment survey 0.229866 Fatigue Coalition 0.248097 Sin embargo 0.226985 Bower JE 0.361676 National Comprehensive Cancer 0.433137 Supportive Oncology 0.240439 Jacobsen PB 0.225244 Cancer Res 0.298674 Fatigue after treatment 0.230762 Radiat Oncol Biol 0.235818 Supportive Oncology Updates 0.236977 Hematol Oncol Clin 0.226159 Fatigue Symptom Inventory 0.230776 Support Care 0.298981 Ganz PA 0.346159 survivors with persistent 0.230866	Comprehensive Cancer Network 0.433487 patients with 0.336679 Donovan KA 0.225133 Pain Symptom Manage 0.518651 Cella D 0.246025 patients treated with 0.224435 Ancoli-Israel S 0.229262 Oncol Nurs Forum 0.973332 citocinas proinflamatorias 0.262356 Care Cancer 0.446044 Portenoy RK 0.231388 Procrit Study Group 0.227164 menor cansancio 0.370471 breast carcinoma survivors 0.265734 patients receiving 0.226133 Clin Oncol 0.504505 Oncol Biol Phys 0.236851 individual with 0.229384 research literature investigating 0.225358 long-term breast carcinoma 0.246503 early stage breast 0.235969 Lee Fatigue Scale 0.226512 cancer patient 0.800328 término cansancio 0.373768	CLICK HERE
1838	National Cancer Institute	Html	es	Tratamiento del cáncer de testículo (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento del cáncer de testículo.	Warde P 0.218827 Compton CC 0.2177 Belt-Dusebout AW 0.219564 Cancer Collaborative Group 0.22935 FossÃ¥ SD 0.255716 germ cell tumor 0.301479 testicular cancer 0.813967 Sin embargo 0.218866 7th ed 0.217529 germ cell tumours 0.262155 Cell Cancer Collaborative 0.240371 cell testicular tumors 0.220056 testicular malignant germ 0.217591 tumor markers 0.216572 International Germ Cell 0.302822 Natl Cancer Inst 0.334587 second cancers 0.223863 contralateral testicular germ 0.218168 cell tumor patients 0.216601 Testicular Cancer Study 0.224272 patients with 0.222118 testicular intraepithelial neoplasia 0.225067 with testicular germ 0.235317 Eur Urol 0.215174 Urol Clin North 0.219868	testicular seminoma 0.246035 Germ Cell Consensus 0.24481 Cell Cancer Consensus 0.272426 >2 cm 0.228724 Cancer Staging Manual 0.263147 European Germ Cell 0.228106 germ cell 0.993431 nonseminomatous germ 0.23506 cicatriz histológica testicular 0.215529 Clin Oncol 0.466287 saco vitelino 0.231013 Clin North Am 0.217469 estadio iii 0.231852 clinical stage 0.215125 Cell Consensus Classification 0.239173 Byrd DR 0.216367 testicular germ-cell tumours 0.215172 cancer consensus group 0.233559 germ cell testis 0.214767 germ cell cancer 0.692466 Children's Cancer Study 0.215431 testicular germ 0.280501 Cancer Study Group 0.229234 AJCC Cancer Staging 0.265329	CLICK HERE
1960	National Cancer Institute	Html	es	Tratamiento del sarcoma uterino (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento del sarcoma uterino.	estadios iva 0.401059 sarcoma uterino causa 0.406591 siguientes procedimientos 0.403992 Estadio IA 0.402022 estadio iv 0.408854 cáncer.ampliar cistoscopia 0.401375 siguientes aspectos 0.404454 Estadio IB 0.402046 estadio ii 0.409805 útero forma 0.405141 Estadio IIIB 0.402011 Estadio IIIC 0.402019 estadios ia 0.401093 vía oral 0.40093 Estadio IIIA 0.402062 rayos x 0.401181 ondas sonoras 0.401284	National Cancer Institute 0.400945 estadios iiia 0.401156 siguientes riesgos 0.400687 áreas anormales.ampliar examen 0.402099 Instituto Nacional 0.401682 PDQ Tratamiento 0.411733 ecograma.ampliar ecografía 0.401623 Physician Data Query 0.403425 último panel 0.401341 estadio iii 0.406282 cuello uterino 0.559914 histerectomía abdominal 0.405298 sarcoma uterino 0.996876 cáncer quizás 0.40452 Estadio IVB 0.402 Estadio IVA 0.401945 extirpa tanta masa 0.402241	CLICK HERE
1965	National Cancer Institute	Html	es	Tratamiento del tumor de Wilms y otros tumores renales infantiles (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento del tumor de Wilms y otros tumores renales infantiles.	carcinoma mioepitelial renal 0.526401 siguientes procedimientos 0.505279 siguientes aspectos 0.505599 efectos secundarios meses 0.505495 siguientes síndromes 0.506829 siguientes razones 0.503795 rayos x 0.510267 niño ayuda 0.504738 estadio v 0.504623 tumores benignos 0.514918 sustancia llamada gadolinio 0.50702 tumores renales 0.951588 tumor renal 0.637779 pelvis renal 0.507303 alta potencia 0.509261 cánceres renales 0.508824 siguientes enfermedades 0.50611 nefroblastomatosis perilobular hiperplásica 0.509412 Antecedentes familiares 0.504021 vejiga almacena 0.505429 siguientes estadios 0.504745 riñón.ampliar ecografía 0.506308 células madre 0.544993 problemas renales 0.514442	adultos jóvenes 0.513748 estadio iv 0.508345 cabo ensayos 0.506023 cuerpo.ampliar anatomía 0.504995 pequeña cantidad 0.51696 estadio ii 0.508321 túbulos renales 0.518212 ondas sonoras 0.510366 efectos tardíos 0.540359 escáner.ampliar exploración 0.503685 PDQ Efectos tardíos 0.519051 Von Hippel-Lindau 0.513101 PDQ Tratamiento 0.517805 determinados cambios 0.504218 nefroma mesoblástico congénito 0.582259 siguientes signos 0.506344 tirosina cinasa 0.506394 siguientes factores 0.505365 siguientes situaciones 0.504547 gen smarcb1 0.504862 células renales 0.823203 Wilms Tumor 0.52815 gran crecimiento 0.51167 Childhood Kidney Cancers 0.504322	CLICK HERE
2104	National Cancer Institute	Html	es	Prevención del cáncer de endometrio (PDQ®)–Versión para profesionales de salud	Sumario de información revisada por expertos sobre factores que influyen en el riesgo de presentar cáncer de endometrio y sobre las investigaciones dirigidas a la prevención de esta enfermedad.	Surgical Adjuvant Breast 0.312551 Obstet Gynecol 0.324802 accessed july 0.303593 Iowa Women Health 0.308818 population-based case-control study 0.304331 available online 0.305054 Cancer Research Fund 0.306547 endometrial carcinoma 0.319197 Breast feeding practices 0.304731 American Cancer Society 0.323044 Prospective Investigation into 0.30657 Disease Control 0.304429 case-control study 0.307735 intentional weight loss 0.305807 risk factors 0.315161 colorectal cancer 0.312231 Cancer Causes Control 0.326606 Natl Cancer Inst 0.357685 Women's Health Study 0.306339 Women's Health Initiative 0.307967 PDQ Prevención 0.303492 Research On Cancer 0.312008 endometrial hyperplasia 0.31494 endometrial cancer 0.992212 Reproductive risk factors 0.308365	European Prospective Investigation 0.306481 investigation into cancer 0.322236 Women's Health 0.310973 endometrial cancer risk 0.612217 Cancer Facts 0.307157 Bowel Project 0.305155 Health Study 0.307565 Nutr Cancer 0.307216 dose-response meta-analysis 0.303563 Cancer Research 0.309943 National Cancer Institute 0.30655 epidemiological studies 0.307756 replacement therapy 0.303602 Breast Cancer Prevention 0.308767 endometrial carcinoma among 0.306561 Clin Oncol 0.303952 breast cancer 0.379165 systematic review 0.305375 PDQ Genetics 0.303535 physical activity 0.307794 Gynecol Cancer 0.308219 Breast Cancer Study 0.308595 National Surgical Adjuvant 0.309763 Women’s Health 0.303756	CLICK HERE
3516	National Cancer Institute	Html	en	Phases of Clinical Trials	Information about the phases of cancer clinical trials. If a new treatment is successful in one phase, it will proceed to further testing in the next phase.	phase 0.792058 new treatment 0.947877 trial phases 0.360482 current standard therapy 0.316008 new cancer treatments 0.34108	phase clinical trials 0.478655 early phases 0.271363 phases 0.375183 drug treatment trials 0.287914	CLICK HERE
3656	National Cancer Institute	Html	en	David Q. Matus, Ph.D.	David Matus studies cellular invasion--a characteristic behavior of metastatic cancer cells--in an evolutionary context.	colon carcinoma cells 0.575003 anchor cell invasion 0.641108 basement membrane 0.798484 transcription factors 0.55171 cell lines 0.544877 Martindale lab 0.540411 cellular basement membrane 0.610463 basement membranes 0.590872 anchor cell 0.729012 reproductive tract 0.559366 graduate school 0.537018 invasion process 0.549999 deep evolutionary roots 0.554576 different nematode species 0.556072 small translucent worm 0.572459 sea anemones 0.537853 Dr. Matus 0.992838 independent research careers 0.559323 genetic control 0.536692 dense sheet-like layer 0.561929 connective tissue underneath 0.560757 —a systematic method 0.560107 uterine cells 0.552149 Caenorhabditis elegans 0.544264 basic biological processes 0.563833	scientist—while training dolphins 0.567297 evolutionary developmental biology 0.55366 vulval cells 0.554372 academic lineage—a trace 0.553945 individual genes 0.558466 Mark Q. Martindale 0.628065 science fair project 0.55475 Stony Brook University 0.569431 metastatic cancer cells 0.596221 mitotic cells 0.54782 scientific career—and 0.537464 anchor cell dividing 0.581016 invasive cell 0.543064 programmed cell death 0.577561 normal cells 0.556326 New York 0.537757 C. elegans 0.565408 anchor cell invasion—and 0.584387 David Q. Matus 0.656523 Cell Biology Department 0.584431 cellular invasion 0.583572 potential drug targets 0.557542 cell behaviors 0.541546 Dr. Martindale 0.549501	CLICK HERE
4330	National Cancer Institute	Html	en	Screening Tests	Information about tests that may be used to screen for cancer in people without symptoms of disease.	Breast Cancer Screening 0.406484 health care provider 0.30932 expert groups 0.265652 Cancer Screening summary 0.902327 fact sheet 0.466524 occult blood tests 0.269438 Mammograms fact sheet 0.267038 Detect Colorectal Cancer 0.350233 Prostate Cancer Screening 0.306727 health care providers 0.256913 PDQ® Breast Cancer 0.380619 Cancer Risk 0.261618 transvaginal ultrasound 0.266045 Ovarian Cancer Screening 0.355679 colorectal cancer 0.408815 routine PSA testing 0.258642 test 0.313731 Genetic Testing fact 0.262194 Skin Cancer Screening 0.305113 heavy smokers ages 0.262129 Colorectal Cancer Screening 0.370971 high risk 0.258361 Testing fact sheet 0.311925 Endometrial Cancer Screening 0.308488	Breast MRI 0.244315 Cervical Cancer Screening 0.31686 women 0.251835 imaging test 0.262647 digital rectal exam 0.25607 prostate cancer deaths 0.288964 helical computed tomography 0.266342 Clinical breast exams 0.268026 PDQ® Colorectal Cancer 0.346246 HPV Testing fact 0.264281 Polyps fact sheet 0.318987 effective ovarian cancer 0.290042 Lung Cancer Screening 0.320215 regular breast self-exams 0.270315 Melanoma fact sheet 0.258634 National Lung Screening 0.295693 Alpha-fetoprotein blood test 0.268207 PDQ® Ovarian Cancer 0.331871 blood test 0.291254 lung cancer deaths 0.300295 Test fact sheet 0.267108 information 0.299153 risk 0.28214 liver cancer 0.25618	CLICK HERE
15662	National Cancer Institute	Html	en	Cancer Disparities	Basic information about cancer disparities in the U.S., factors that contribute to the disproportionate burden of cancer in some groups, and examples of disparities in incidence and mortality among certain populations.	bile duct cancer 0.529873 colorectal cancer deaths 0.551836 colorectal cancer screening 0.555974 racial/ethnic minority groups 0.531719 cancer disparities—in particular 0.523151 racial/ethnic groups 0.863683 behavioral risk factors 0.505154 triple-negative breast cancer 0.524689 colorectal cancer 0.712116 key cancer incidence 0.561455 Asian Pacific Islanders 0.491901 cancer types 0.491276 racial/ethnic differences 0.492357 aggressive prostate cancers 0.499019 population groups 0.55611 white women 0.564935 higher death rates 0.607232 cancer health disparities 0.660515 higher rates 0.558073 prostate cancers 0.505687 clinical trial participation 0.493429 mortality disparities 0.547391 quality health care 0.505421 U.S. racial/ethnic groups 0.529263 United States 0.628581	minority racial/ethnic groups 0.535197 African Americans 0.773054 certain groups 0.517997 dense urban neighborhoods 0.497746 African American men 0.689721 higher socioeconomic status 0.531761 cancer measures 0.502411 excessive alcohol intake 0.493381 higher cancer burden 0.573329 environmental risk factors 0.507025 health care 0.541481 African American women 0.787066 colorectal cancer incidence 0.649355 American Indians/Alaska Natives 0.584845 specific disparities 0.531133 medically underserved individuals 0.505673 effective health care 0.506095 breast cancer 0.54205 statewide colorectal cancer 0.547339 biological differences 0.594269 cancer disparities 0.882383 late-stage cancer 0.50232 prostate cancer 0.522723 cancer 0.915156	CLICK HERE